Companies: 10,795·Total market cap: $144.5T
Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc.

LSTANASDAQHealthcare● Active
$3.48
+$0.13(+3.88%)
Market Cap$31690237
P/E Ratio
52W High$5.07
52W Low$1.81

Lisata Therapeutics, Inc.(LSTA)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

lsta · 股价预测 · 2 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 2 位华尔街分析师

SellBuy

Hold

2 位分析师

共识

评级分布

Strong Buy
0
Buy
0
Hold
2
Sell
0
Strong Sell
0
合计: 2 · 买入占比: 0.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $3.48

Lisata Therapeutics, Inc.(LSTA)的分析师共识为 Hold,基于过去 3 个月内 2 位华尔街分析师的评级。LSTA 的 12 个月平均目标价为 $0.00,相对当前价 $3.48 代表 +0.0% 的潜在上行空间。

短期股价预测

Bear

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$3.613.80%

1-day model range: $3.58–$3.64. Peak: $3.64 (+3.80%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

43%36%21%
6Buy
5Neutral
3Sell
RSI (14)68.0Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · LSTA · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$3.43BUY
MA 10$3.38BUY
MA 20$3.28BUY
MA 50$3.68SELL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $LSTA · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$3.42BUY
EMA 10$3.38BUY
EMA 20$3.36BUY
EMA 50$3.60SELL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $LSTA · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2026-05-15
Downgrade ↓
BuyNeutral
Brookline Capital2026-01-21
Downgrade ↓
BuyHold
HC Wainwright & Co.2025-08-21
Maintains
BuyBuy
Brookline Capital2025-07-15
Maintains
BuyBuy
HC Wainwright & Co.2024-12-11
Maintains
BuyBuy
HC Wainwright & Co.2024-11-21
Maintains
BuyBuy
HC Wainwright & Co.2024-09-18
Maintains
BuyBuy
HC Wainwright & Co.2024-08-13
Maintains
BuyBuy
HC Wainwright & Co.2024-07-19
Maintains
BuyBuy
HC Wainwright & Co.2024-07-10
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Lisata Therapeutics, Inc. (LSTA) stock. Of the recent 20 rating actions, 0 were upgrades and 2 were downgrades. 2 analysts currently cover LSTA.

分析师推荐趋势

Buy ratings101
Hold ratings01↑ +1
Sell ratings00

LSTA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$0M

↓ 99.3% YoY

Revenue Next Year

$0M

↑ 304.2% YoY

EPS This Year

$-2.33

EPS Next Year

$-1.09

↓ 53.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast LSTA EPS of $-2.33 for the current fiscal year, based on estimates from 1 analysts. The LSTA revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

LSTA 股价预测由两类独立数据源支撑:来自 2 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。LSTA 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Hold。

LSTA 的短期预测(明日)为 $3.61(+3.80%)。

Lisata Therapeutics, Inc. 在 NASDAQ 上市,代码 LSTA。LSTA 在 2027 年的整体展望偏中性/分化,在覆盖分析师中约 0% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

LSTA 预测 · 8 个问题

根据 2 位华尔街分析师,LSTA 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $3.48,隐含约 +0.0% 的上行空间。

LSTA 目标价LSTA 分析师目标价LSTA 12个月目标价目标价 LSTA

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.